No reported Insider Trades available for Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd Jointly holding in the Trendlyne database.
Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd Jointly holding's has made SAST transactions in Aurobindo Pharma Ltd. recently where a Pledge of 3,400,000 shares done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Axis Clinicals Limited (jointly holding with Trident Chemphar Limited and RPR Sons Advisors Pvt.Ltd) | Promoter | Pledge | 24 Dec 2024 | 3,400,000 | 3,410,000 | - | - | 17 Feb 2021 17 Feb 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 1,250,000 | 3,350,000 | - | - | 09 Jul 2021 09 Jul 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 10,000 | 2,100,000 | 0% | - | 08 Jul 2021 08 Jul 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 2,630,000 | 5,980,000 | - | - | 11 Aug 2021 11 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 120,000 | 6,500,000 | - | - | 13 Aug 2021 13 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 400,000 | 6,380,000 | - | - | 13 Aug 2021 13 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 205,000 | 6,970,000 | - | - | 16 Aug 2021 16 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 265,000 | 6,765,000 | - | - | 16 Aug 2021 16 Aug 2021 |
SAST (Reg31) | - | Creation |